Department of Surgery; Division of Trauma, Surgical Critical Care, Burns and Acute Care Surgery, UC San Diego, CA.
Department of Surgery; Division of Trauma, Surgical Critical Care, Burns and Acute Care Surgery, UC San Diego, CA. Electronic address: https://twitter.com/TWCostantini.
Surgery. 2022 Oct;172(4):1057-1064. doi: 10.1016/j.surg.2022.06.008. Epub 2022 Aug 18.
Current guidelines recommend that patients with choledocholithiasis undergo same-admission cholecystectomy. The compliance with this guideline is poor in elderly patients. We hypothesized that elderly patients treated with endoscopic retrograde cholangiopancreatography (ERCP) alone would have higher complication and readmission rates than the patients treated with cholecystectomy.
The Nationwide Readmissions Database was queried for all patients aged ≥65 years with admission for choledocholithiasis January to June 2016. The patients were divided based on index treatment received: (1) no intervention; (2) ERCP alone; or (3) cholecystectomy. Multivariate analyses identified predictors of cholecystectomy during index admission and of readmissions.
A total of 16,121 patients with choledocholithiasis were admitted; 38.4% underwent cholecystectomy, 37.6% endoscopic retrograde cholangiopancreatography alone, and 24.0% no intervention. The patients not receiving a cholecystectomy were more likely to be older, female, have a higher Elixhauser score, do-not-resuscitate status, and at a teaching hospital (all P < .001). Emergency readmissions for recurrent biliary disease were lowest in patients undoing a cholecystectomy (2.2% vs 9.2% endoscopic retrograde cholangiopancreatography and 12.4% no intervention, P < .001), as were readmissions for complications (3.6% vs 5.5% and 7.8%, P < .001). Cholecystectomy reduced rates of readmissions for recurrent disease (odds ratio 0.168, P < .001), for complications (odds ratio 0.540, P < .001), and death during readmission (odds ratio 0.503, P = .007); endoscopic retrograde cholangiopancreatography alone reduced only rates of readmissions. Age was not a predictor of readmission or death.
Index admission cholecystectomy is associated with a lower risk of readmission for biliary disease or complications, as well as death during readmission, in elderly patients. Age alone is not predictive of outcomes; surgical intervention should be guided by clinical condition, comorbidities, and patient preference.
目前的指南建议胆总管结石患者接受入院同期胆囊切除术。然而,在老年患者中,这一指南的遵循情况较差。我们推测,仅接受内镜逆行胰胆管造影术(ERCP)治疗的老年患者的并发症和再入院率会高于接受胆囊切除术的患者。
我们在 2016 年 1 月至 6 月期间,通过全国再入院数据库查询了所有年龄≥65 岁、因胆总管结石入院的患者。根据患者的指数治疗方法将其分为三组:(1)无干预;(2)仅 ERCP;或(3)胆囊切除术。多变量分析确定了指数入院期间行胆囊切除术的预测因素以及再入院的预测因素。
共有 16121 例胆总管结石患者入院;38.4%的患者接受了胆囊切除术,37.6%仅接受了 ERCP,24.0%的患者未接受任何干预。未接受胆囊切除术的患者更可能年龄较大、女性、Elixhauser 评分更高、无复苏意愿以及在教学医院就诊(均 P<.001)。行胆囊切除术的患者急诊再发胆道疾病的比例最低(2.2%比 ERCP 组的 9.2%和无干预组的 12.4%,P<.001),并发症再入院的比例也最低(3.6%比 ERCP 组的 5.5%和无干预组的 7.8%,P<.001)。胆囊切除术降低了再发疾病(比值比 0.168,P<.001)、并发症(比值比 0.540,P<.001)和再入院期间死亡(比值比 0.503,P=.007)的再入院率;仅 ERCP 降低了再入院率。年龄不是再入院或死亡的预测因素。
在老年患者中,入院时行胆囊切除术与较低的胆道疾病或并发症再入院风险以及再入院期间死亡风险相关。年龄本身并不能预测结局;手术干预应根据临床情况、合并症和患者意愿来指导。